Shruthi Kanthaje
Chandigarh, CH 160012, India
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Expanding frontiers in liquid biopsy-discovery and validation of circulating biomarkers in renal cell carcinoma and bladder cancer.
Journal: International review of cell and molecular biology
Published: February 12, 2025
Bacterial metabolite butyrate in modulating sorafenib-targeted microRNAs to curtail its resistance in hepatocellular carcinoma.
Journal: Journal of cancer research and clinical oncology
Published: September 27, 2022
miR-23b-3p Modulating Cytoprotective Autophagy and Glutamine Addiction in Sorafenib Resistant HepG2, a Hepatocellular Carcinoma Cell Line.
Journal: Genes
Published: June 16, 2022
Circulating metabolite biomarkers: a game changer in the human prostate cancer diagnosis.
Journal: Journal of cancer research and clinical oncology
Published: April 20, 2022
Genotyping of multi drug resistant Bacteroides fragilis group of clinical isolates from mangalore, south India.
Journal: Indian journal of medical microbiology
Published: February 21, 2021
Repertoires of MicroRNA-30 family as gate-keepers in lung cancer.
Journal: Frontiers in bioscience (Scholar edition)
Published: February 04, 2021
Vimentin as a potential therapeutic target in sorafenib resistant HepG2, a HCC model cell line.
Journal: Clinical and molecular hepatology
Published: March 18, 2019
Association of liver cirrhosis severity with type 2 diabetes mellitus in hepatocellular carcinoma.
Journal: Experimental biology and medicine (Maywood, N.J.)
Published: December 01, 2017
Sorafenib response in hepatocellular carcinoma: MicroRNAs as tuning forks.
Journal: Hepatology research : the official journal of the Japan Society of Hepatology
Published: July 31, 2017
Crosstalk between microRNA-122 and FOX family genes in HepG2 cells.
Journal: Experimental biology and medicine (Maywood, N.J.)
Published: November 30, 2016
Showing 1-10 of 10
Last Updated: 09/26/2026